The global Crohn's Disease Diagnostic and Therapeutic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Crohn's Disease Diagnostic and Therapeutic is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Crohn's Disease Diagnostic and Therapeutic is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Crohn's Disease Diagnostic and Therapeutic in Clinic is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Crohn's Disease Diagnostic and Therapeutic include AbbVie, Celgene Corporation, Genetech, Janssen Biotech, Johnson & Johnson, Pfizer, Prometheus Laboratories, Salix Pharmaceuticals and Takeda's Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Crohn's Disease Diagnostic and Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Crohn's Disease Diagnostic and Therapeutic.
Report Scope
The Crohn's Disease Diagnostic and Therapeutic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Crohn's Disease Diagnostic and Therapeutic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Crohn's Disease Diagnostic and Therapeutic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Celgene Corporation
Genetech
Janssen Biotech
Johnson & Johnson
Pfizer
Prometheus Laboratories
Salix Pharmaceuticals
Takeda's Pharmaceutical
Segment by Type
Blood Tests
Fecal Test
Colonoscopy
Flexible Sigmoidoscopy
Computerized Tomography
Magnetic Resonance Imaging
Capsule Endoscopy
Segment by Application
Clinic
Hospital
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Crohn's Disease Diagnostic and Therapeutic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Crohn's Disease Diagnostic and Therapeutic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Blood Tests
1.2.3 Fecal Test
1.2.4 Colonoscopy
1.2.5 Flexible Sigmoidoscopy
1.2.6 Computerized Tomography
1.2.7 Magnetic Resonance Imaging
1.2.8 Capsule Endoscopy
1.3 Market by Application
1.3.1 Global Crohn's Disease Diagnostic and Therapeutic Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinic
1.3.3 Hospital
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Crohn's Disease Diagnostic and Therapeutic Market Perspective (2019-2030)
2.2 Crohn's Disease Diagnostic and Therapeutic Growth Trends by Region
2.2.1 Global Crohn's Disease Diagnostic and Therapeutic Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Crohn's Disease Diagnostic and Therapeutic Historic Market Size by Region (2019-2024)
2.2.3 Crohn's Disease Diagnostic and Therapeutic Forecasted Market Size by Region (2025-2030)
2.3 Crohn's Disease Diagnostic and Therapeutic Market Dynamics
2.3.1 Crohn's Disease Diagnostic and Therapeutic Industry Trends
2.3.2 Crohn's Disease Diagnostic and Therapeutic Market Drivers
2.3.3 Crohn's Disease Diagnostic and Therapeutic Market Challenges
2.3.4 Crohn's Disease Diagnostic and Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Crohn's Disease Diagnostic and Therapeutic Players by Revenue
3.1.1 Global Top Crohn's Disease Diagnostic and Therapeutic Players by Revenue (2019-2024)
3.1.2 Global Crohn's Disease Diagnostic and Therapeutic Revenue Market Share by Players (2019-2024)
3.2 Global Crohn's Disease Diagnostic and Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Crohn's Disease Diagnostic and Therapeutic Revenue
3.4 Global Crohn's Disease Diagnostic and Therapeutic Market Concentration Ratio
3.4.1 Global Crohn's Disease Diagnostic and Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Crohn's Disease Diagnostic and Therapeutic Revenue in 2023
3.5 Crohn's Disease Diagnostic and Therapeutic Key Players Head office and Area Served
3.6 Key Players Crohn's Disease Diagnostic and Therapeutic Product Solution and Service
3.7 Date of Enter into Crohn's Disease Diagnostic and Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Crohn's Disease Diagnostic and Therapeutic Breakdown Data by Type
4.1 Global Crohn's Disease Diagnostic and Therapeutic Historic Market Size by Type (2019-2024)
4.2 Global Crohn's Disease Diagnostic and Therapeutic Forecasted Market Size by Type (2025-2030)
5 Crohn's Disease Diagnostic and Therapeutic Breakdown Data by Application
5.1 Global Crohn's Disease Diagnostic and Therapeutic Historic Market Size by Application (2019-2024)
5.2 Global Crohn's Disease Diagnostic and Therapeutic Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Crohn's Disease Diagnostic and Therapeutic Market Size (2019-2030)
6.2 North America Crohn's Disease Diagnostic and Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Crohn's Disease Diagnostic and Therapeutic Market Size by Country (2019-2024)
6.4 North America Crohn's Disease Diagnostic and Therapeutic Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Crohn's Disease Diagnostic and Therapeutic Market Size (2019-2030)
7.2 Europe Crohn's Disease Diagnostic and Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Crohn's Disease Diagnostic and Therapeutic Market Size by Country (2019-2024)
7.4 Europe Crohn's Disease Diagnostic and Therapeutic Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Crohn's Disease Diagnostic and Therapeutic Market Size (2019-2030)
8.2 Asia-Pacific Crohn's Disease Diagnostic and Therapeutic Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Crohn's Disease Diagnostic and Therapeutic Market Size by Region (2019-2024)
8.4 Asia-Pacific Crohn's Disease Diagnostic and Therapeutic Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Crohn's Disease Diagnostic and Therapeutic Market Size (2019-2030)
9.2 Latin America Crohn's Disease Diagnostic and Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Crohn's Disease Diagnostic and Therapeutic Market Size by Country (2019-2024)
9.4 Latin America Crohn's Disease Diagnostic and Therapeutic Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Crohn's Disease Diagnostic and Therapeutic Market Size (2019-2030)
10.2 Middle East & Africa Crohn's Disease Diagnostic and Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Crohn's Disease Diagnostic and Therapeutic Market Size by Country (2019-2024)
10.4 Middle East & Africa Crohn's Disease Diagnostic and Therapeutic Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Crohn's Disease Diagnostic and Therapeutic Introduction
11.1.4 AbbVie Revenue in Crohn's Disease Diagnostic and Therapeutic Business (2019-2024)
11.1.5 AbbVie Recent Development
11.2 Celgene Corporation
11.2.1 Celgene Corporation Company Detail
11.2.2 Celgene Corporation Business Overview
11.2.3 Celgene Corporation Crohn's Disease Diagnostic and Therapeutic Introduction
11.2.4 Celgene Corporation Revenue in Crohn's Disease Diagnostic and Therapeutic Business (2019-2024)
11.2.5 Celgene Corporation Recent Development
11.3 Genetech
11.3.1 Genetech Company Detail
11.3.2 Genetech Business Overview
11.3.3 Genetech Crohn's Disease Diagnostic and Therapeutic Introduction
11.3.4 Genetech Revenue in Crohn's Disease Diagnostic and Therapeutic Business (2019-2024)
11.3.5 Genetech Recent Development
11.4 Janssen Biotech
11.4.1 Janssen Biotech Company Detail
11.4.2 Janssen Biotech Business Overview
11.4.3 Janssen Biotech Crohn's Disease Diagnostic and Therapeutic Introduction
11.4.4 Janssen Biotech Revenue in Crohn's Disease Diagnostic and Therapeutic Business (2019-2024)
11.4.5 Janssen Biotech Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Detail
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Crohn's Disease Diagnostic and Therapeutic Introduction
11.5.4 Johnson & Johnson Revenue in Crohn's Disease Diagnostic and Therapeutic Business (2019-2024)
11.5.5 Johnson & Johnson Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Crohn's Disease Diagnostic and Therapeutic Introduction
11.6.4 Pfizer Revenue in Crohn's Disease Diagnostic and Therapeutic Business (2019-2024)
11.6.5 Pfizer Recent Development
11.7 Prometheus Laboratories
11.7.1 Prometheus Laboratories Company Detail
11.7.2 Prometheus Laboratories Business Overview
11.7.3 Prometheus Laboratories Crohn's Disease Diagnostic and Therapeutic Introduction
11.7.4 Prometheus Laboratories Revenue in Crohn's Disease Diagnostic and Therapeutic Business (2019-2024)
11.7.5 Prometheus Laboratories Recent Development
11.8 Salix Pharmaceuticals
11.8.1 Salix Pharmaceuticals Company Detail
11.8.2 Salix Pharmaceuticals Business Overview
11.8.3 Salix Pharmaceuticals Crohn's Disease Diagnostic and Therapeutic Introduction
11.8.4 Salix Pharmaceuticals Revenue in Crohn's Disease Diagnostic and Therapeutic Business (2019-2024)
11.8.5 Salix Pharmaceuticals Recent Development
11.9 Takeda's Pharmaceutical
11.9.1 Takeda's Pharmaceutical Company Detail
11.9.2 Takeda's Pharmaceutical Business Overview
11.9.3 Takeda's Pharmaceutical Crohn's Disease Diagnostic and Therapeutic Introduction
11.9.4 Takeda's Pharmaceutical Revenue in Crohn's Disease Diagnostic and Therapeutic Business (2019-2024)
11.9.5 Takeda's Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
AbbVie
Celgene Corporation
Genetech
Janssen Biotech
Johnson & Johnson
Pfizer
Prometheus Laboratories
Salix Pharmaceuticals
Takeda's Pharmaceutical
*If Applicable.